Duloxetine 20 MG Delayed Release Oral Capsule — RxCUI 596926
RxNorm drug concept · Semantic clinical drug
RxCUI 596926
Semantic clinical drug · SCD
● Current RxNorm concept 103 FDA products
289 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI596926
Official nameDuloxetine 20 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asduloxetine 20 MG (as duloxetine HCl 22.4 MG) Delayed Release Oral Capsule
FDA products mapped103
Package NDCs mapped289
Reported Medicaid activity (SDUD)4,098,603 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Duloxetine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats major depressive disorder and generalized anxiety disorder. It is also used for diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain such as low back or os...
- Take it by mouth, usually once a day, with or without food. Swallow the capsule whole and don’t crush, chew, or open it, unless you have Drizalma Sprinkle, which can be opened over...
- Nausea, dry mouth, sleepiness, constipation, less appetite, and sweating are the most common. Headache and dizziness also occur. Call your doctor for yellow skin or eyes, a blister...
- Please don’t stop suddenly. Stopping abruptly can cause discontinuation symptoms, so your prescriber will lower the dose gradually. Check in with them before making any change.
🕸️ Concept Web — How Duloxetine 20 MG Delayed Release Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Duloxetine 20 MG Delayed Release Oral Capsule
RxCUI 596926 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Duloxetine
72625IN
-
Duloxetine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cymbalta
482574BN
-
Cymbalta
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Duloxetine Delayed Release Oral Capsule
540628SCDF -
Duloxetine Oral Product
1161267SCDG -
Duloxetine Pill
1161268SCDG -
Duloxetine Delayed Release Oral Capsule [Cymbalta]
540631SBDF -
Cymbalta Oral Product
1174445SBDG -
Cymbalta Pill
1174446SBDG -
Delayed Release Oral Capsule
316995DF -
Oral Product
1151131DFG - +1 more in this family
-
Duloxetine Delayed Release Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Duloxetine 20 MG
596925SCDC -
Duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta]
596928SBD -
Duloxetine 20 MG [Cymbalta]
596927SBDC
-
Duloxetine 20 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Duloxetine 20 MG
SCDC · 596925 -
Duloxetine Delayed Release Oral Capsule
SCDF · 540628 -
Duloxetine Oral Product
SCDG · 1161267 -
Duloxetine Pill
SCDG · 1161268
Brand-Name Concepts
-
Duloxetine 20 MG Delayed Release Oral Capsule [Cymbalta]
SBD · 596928 -
Duloxetine 20 MG [Cymbalta]
SBDC · 596927 -
Duloxetine Delayed Release Oral Capsule [Cymbalta]
SBDF · 540631 -
Cymbalta Oral Product
SBDG · 1174445 -
Cymbalta Pill
SBDG · 1174446 -
Cymbalta
BN · 482574
📦 FDA Products & Package NDCs
103 products · 289 package NDCs
289 package NDCs map to RxCUI 596926 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00002-3235-60 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3235-60) | Cymbalta | Eli Lilly and Company | 2004-08-24 |
| 00228-2890-06 | 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0228-2890-0... | Duloxetine | Actavis Pharma, Inc. | 2013-12-17 |
| 00228-2891-03 | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0228-2891-0... | Duloxetine | Actavis Pharma, Inc. | 2013-12-17 |
| 00228-2891-50 | 500 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0228-2891-... | Duloxetine | Actavis Pharma, Inc. | 2014-09-05 |
| 00228-2892-03 | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0228-2892-0... | Duloxetine | Actavis Pharma, Inc. | 2013-12-17 |
| 00228-2892-96 | 1000 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0228-2892... | Duloxetine | Actavis Pharma, Inc. | 2014-09-05 |
| 00615-8494-39 | 30 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (0615-8494-39) | Duloxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-01-04 |
| 00615-8495-05 | 15 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (0615-8495-05) | Duloxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-01-03 |
| 00615-8495-39 | 30 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (0615-8495-39) | Duloxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-01-03 |
| 00615-8496-05 | 15 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (0615-8496-05) | Duloxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2023-12-29 |
| 00615-8496-28 | 28 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (0615-8496-28) | Duloxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-12-31 |
| 00615-8496-39 | 30 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (0615-8496-39) | Duloxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2023-12-29 |
| 25000-0608-06 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (25000-608-06) | Duloxetine | MARKSANS PHARMA LIMITED | 2022-05-27 |
| 25000-0609-03 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (25000-609-03) | Duloxetine | MARKSANS PHARMA LIMITED | 2022-05-27 |
| 25000-0609-07 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (25000-609-07) | Duloxetine | MARKSANS PHARMA LIMITED | 2022-05-27 |
| 25000-0610-03 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (25000-610-03) | Duloxetine | MARKSANS PHARMA LIMITED | 2022-05-27 |
| 25000-0610-07 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (25000-610-07) | Duloxetine | MARKSANS PHARMA LIMITED | 2022-05-27 |
| 27241-0097-05 | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-097-05) | Duloxetine | Ajanta Pharma USA Inc. | 2021-10-18 |
| 27241-0097-06 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-097-06) | Duloxetine | Ajanta Pharma USA Inc. | 2017-03-16 |
| 27241-0097-10 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-097-10) | Duloxetine | Ajanta Pharma USA Inc. | 2017-03-16 |
| 27241-0097-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-097-90) | Duloxetine | Ajanta Pharma USA Inc. | 2021-10-18 |
| 27241-0098-03 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-098-03) | Duloxetine | Ajanta Pharma USA Inc. | 2017-03-16 |
| 27241-0098-09 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-098-09) | Duloxetine | Ajanta Pharma USA Inc. | 2017-03-16 |
| 27241-0098-10 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-098-10) | Duloxetine | Ajanta Pharma USA Inc. | 2017-03-16 |
| 27241-0099-03 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-099-03) | Duloxetine | Ajanta Pharma USA Inc. | 2017-03-16 |
| 27241-0099-40 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-099-40) | Duloxetine | Ajanta Pharma USA Inc. | 2021-10-18 |
| 27241-0099-90 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-099-90) | Duloxetine | Ajanta Pharma USA Inc. | 2017-03-16 |
| 27241-0164-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-164-30) | Duloxetine | Ajanta Pharma USA Inc. | 2019-03-25 |
| 31722-0168-01 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-168-01) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0168-05 | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-168-05) | Duloxetine | Camber Pharmaceuticals, Inc. | 2024-06-29 |
| 31722-0168-10 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-168-10) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0168-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-168-30) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0168-31 | 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (31722-168-31) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0168-32 | 105 CAPSULE, DELAYED RELEASE in 1 CARTON (31722-168-32) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0168-60 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-168-60) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0168-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-168-90) | Duloxetine | Camber Pharmaceuticals, Inc. | 2024-06-29 |
| 31722-0169-01 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-169-01) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0169-10 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-169-10) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0169-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-169-30) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0169-31 | 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (31722-169-31) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0169-32 | 105 CAPSULE, DELAYED RELEASE in 1 CARTON (31722-169-32) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0169-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-169-90) | Duloxetine | Camber Pharmaceuticals, Inc. | 2024-06-29 |
| 31722-0170-01 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-170-01) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0170-10 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-170-10) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0170-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-170-30) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0170-31 | 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (31722-170-31) | Duloxetine | Camber Pharmaceuticals, Inc. | 2020-12-30 |
| 31722-0170-90 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-170-90) | Duloxetine | Camber Pharmaceuticals, Inc. | 2024-06-29 |
| 33342-0160-09 | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33342-160-09) | Duloxetine Hydrochloride | Macleods Pharmaceuticals Limited | 2017-03-24 |
| 33342-0160-10 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33342-160-10) | Duloxetine Hydrochloride | Macleods Pharmaceuticals Limited | 2017-03-24 |
| 33342-0160-12 | 10 BLISTER PACK in 1 CARTON (33342-160-12) / 10 CAPSULE, DE... | Duloxetine Hydrochloride | Macleods Pharmaceuticals Limited | 2017-03-24 |
Observed labelers:
Asclemed USA, Inc. (23) ·
Bryant Ranch Prepack (19) ·
Camber Pharmaceuticals, Inc. (19) ·
Sun Pharmaceutical Industries, Inc. (17) ·
Inventia Healthcare Limited. (15) ·
Ascend Laboratories, LLC (13)
· +29 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.